Caffeic acid may be a promising management for the treatment of leukopenia. The findings should be interpreted with caution due to the high risk of bias in many included trials and the limited generalizability, as all studies were conducted in China.
Dai et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: